Compare RECT & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | RECT | IXHL |
|---|---|---|
| Founded | 1997 | 2001 |
| Country | Singapore | Australia |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.6M | 49.1M |
| IPO Year | 2024 | N/A |
| Metric | RECT | IXHL |
|---|---|---|
| Price | $1.82 | $0.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.2K | ★ 24.9M |
| Earning Date | 07-31-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $32,594,177.00 | $12,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $15.61 | ★ N/A |
| Revenue Growth | ★ 5.91 | N/A |
| 52 Week Low | $1.79 | $0.08 |
| 52 Week High | $7.68 | $2.25 |
| Indicator | RECT | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 27.15 | 49.46 |
| Support Level | $1.79 | $0.38 |
| Resistance Level | $2.12 | $0.45 |
| Average True Range (ATR) | 0.11 | 0.04 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 9.09 | 39.16 |
Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks. Additionally the company has added auxiliary products such as industrial hardware tools and electrical hardware required for construction sites.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.